全文获取类型
收费全文 | 3623篇 |
免费 | 239篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 145篇 |
妇产科学 | 83篇 |
基础医学 | 477篇 |
口腔科学 | 78篇 |
临床医学 | 336篇 |
内科学 | 825篇 |
皮肤病学 | 45篇 |
神经病学 | 230篇 |
特种医学 | 242篇 |
外科学 | 491篇 |
综合类 | 42篇 |
一般理论 | 3篇 |
预防医学 | 342篇 |
眼科学 | 11篇 |
药学 | 268篇 |
中国医学 | 5篇 |
肿瘤学 | 218篇 |
出版年
2023年 | 26篇 |
2022年 | 25篇 |
2021年 | 62篇 |
2020年 | 38篇 |
2019年 | 67篇 |
2018年 | 69篇 |
2017年 | 54篇 |
2016年 | 66篇 |
2015年 | 58篇 |
2014年 | 79篇 |
2013年 | 130篇 |
2012年 | 189篇 |
2011年 | 210篇 |
2010年 | 129篇 |
2009年 | 128篇 |
2008年 | 189篇 |
2007年 | 212篇 |
2006年 | 208篇 |
2005年 | 208篇 |
2004年 | 168篇 |
2003年 | 167篇 |
2002年 | 159篇 |
2001年 | 109篇 |
2000年 | 94篇 |
1999年 | 82篇 |
1998年 | 36篇 |
1997年 | 37篇 |
1996年 | 50篇 |
1995年 | 29篇 |
1994年 | 26篇 |
1993年 | 37篇 |
1992年 | 52篇 |
1991年 | 52篇 |
1990年 | 80篇 |
1989年 | 49篇 |
1988年 | 48篇 |
1987年 | 42篇 |
1986年 | 34篇 |
1985年 | 43篇 |
1984年 | 26篇 |
1983年 | 17篇 |
1982年 | 18篇 |
1981年 | 20篇 |
1980年 | 21篇 |
1979年 | 25篇 |
1978年 | 19篇 |
1977年 | 18篇 |
1975年 | 16篇 |
1974年 | 25篇 |
1970年 | 15篇 |
排序方式: 共有3866条查询结果,搜索用时 15 毫秒
71.
Meng-Lay Lin Hetal Patel Judit Remenyi Christopher R.S. Banerji Chun-Fui Lai Manikandan Periyasamy Ylenia Lombardo Claudia Busonero Silvia Ottaviani Alun Passey Philip R. Quinlan Colin A. Purdie Lee B. Jordan Alastair M. Thompson Richard S. Finn Oscar M. Rueda Carlos Caldas Jesus Gil R. Charles Coombes Frances V. Fuller-Pace Andrew E. Teschendorff Laki Buluwela Simak Ali 《Oncotarget》2015,6(25):21685-21703
72.
Kristine Blix Sigrid K. Brækkan Saskia le Cessie Finn E. Skjeldestad Suzanne C. Cannegieter John-Bjarne Hansen 《European journal of epidemiology》2014,29(4):277-284
Whether the high incidence of venous thromboembolism (VTE) in the elderly can be attributed to cancer is not well studied. We assessed the impact of cancer on risk of VTE in young, middle-aged and elderly. 26,094 subjects without a history of cancer or VTE were recruited from the Tromsø study. Incident cancer (n = 2,290) and VTE (n = 531) were recorded from baseline (1994–1995) through December 31st, 2009. Cox regression with cancer as time-varying exposure was used to calculate hazard ratios with 95 % confidence intervals (CI). Overt cancer was associated with a fivefold (95 %CI 4.3, 6.7) increased risk of VTE, with an age-dependent gradient from 26-fold (95 %CI 12.1, 56.5) increased in the young, ninefold (95 % CI 6.6, 12.7) increased in the middle-aged, and threefold (95 % CI 2.5, 4.5) increased risk in the elderly. The population attributable risks were 14, 27 and 18 %, respectively. Conclusion: The relative risk of VTE by cancer were higher in young compared to elderly subjects, but the proportion of VTEs in the population due to cancer did not differ much across age groups. Our findings indicate that the increased risk of VTE by advancing age cannot be attributed to higher incidence of cancer in the elderly. 相似文献
73.
74.
Cathal P. O’Brien Sarah E. Taylor John J. O’Leary Stephen P. Finn 《Lung cancer (Amsterdam, Netherlands)》2014
Recent advances in the understanding of the molecular basis of cancer and the development of molecular diagnostics based on this knowledge have done much to progress the fields of oncology and pathology. Technological developments such as Next Generation Sequencing (NGS) and multiplex assays have made feasible the widespread adoption of molecular diagnostics for clinical use. While these developments and advances carry much promise, there are pitfalls to implementing this testing. 相似文献
75.
76.
Rubenstein MH Finn AV Leinbach RC Hollenbach S Aretz HT Virmani R Gold HK 《Journal of the American College of Cardiology》2004,43(2):287-294
OBJECTIVES: This study was designed to determine in a dog model of coronary thrombosis whether short-term eptifibatide (Ep) combined with low-dose plasminogen activator (rt-PA) inhibits platelet recruitment at sites of endothelial damage after normalization of platelet function. BACKGROUND: Ep plus reduced-dose rt-PA has not previously been shown to render a recanalized coronary artery resistant to platelet recruitment after normalization of platelet function. METHOD: Inhibition of platelet recruitment was studied by scanning electron microscopy (SEM) in a canine model of left anterior descending (LAD) thrombosis. In phase I treatment groups were: 1) Ep (n = 6); 2) Ep + rt-PA (n = 6); 3) rt-PA (n = 6); and 4) placebo (n = 4). Coronary blood flow was monitored and LAD segments excised for SEM after 90-min infusion of study drug. In phase II, dogs were randomized to Ep alone (n = 5) or to Ep + rt-PA (n = 5). Coronary blood flow was monitored during and 120 min after cessation of drug when platelet function had returned to normal and LAD segments were excised. RESULTS: All animals except placebo showed reflow. In phase I, SEM showed an absence of platelet aggregates with Ep alone and with Ep + rt-PA, but not with rt-PA alone. In phase II, SEM showed an intimal surface devoid of mural thrombus and platelet aggregates only in Ep + rt-PA treated arteries. Ep-alone treated arteries showed new platelet aggregates at sites of residual mural thrombus. CONCLUSIONS: Short-term infusion Ep plus low-dose rt-PA acutely neutralizes the ability of damaged endothelial surfaces to recruit new platelets by inhibiting platelet aggregation and eliminating residual mural thrombus. 相似文献
77.
Waage A Gimsing P Juliusson G Turesson I Gulbrandsen N Eriksson T Hjorth M Nielsen JL Lenhoff S Westin J Wislöff F;Nordic Myeloma Study Group 《British journal of haematology》2004,125(2):149-155
Sixty-five patients who were primary or secondary refractory to melphalan/prednisone or other type of chemotherapy, or relapsed within 6 months after high dose chemotherapy with stem cell support, were given thalidomide at a dose of 200 mg/d escalating to 800 mg. The patients were followed for a median of 2 years and 22 weeks. Response was evaluated according to M-protein reduction combined with improvement of haemoglobin (Hb) concentration, renal function and pain. Altogether, 14% of patients had a minor response, 14% partial response and 6% complete response. Median survival was 12 months and 29% were alive at last contact. Decline of M protein started early and a minimum 25% reduction of M protein was detected in 14 of 20 responders (70%) after 3 weeks, and in 20 of 22 responders (91%) after 5 weeks of treatment. Reduction of M protein continued for 3 months and further decline was observed in only four patients. The Hb concentration showed a different time course, with a significant increase after 3 months and further increases continued for up to 12 months. Blood concentration levels of thalidomide from 40 patients were used to evaluate the pharmacokinetics of the drug. Rate of absorption, rate of elimination, volume of distribution, clearance and elimination half-life were calculated to be 0.200/h, 0.140/h, 0.886 l/kg, 0.126 l/h/kg and 4.98 h respectively. We found no relationship between thalidomide concentration and effect after 12 weeks. 相似文献
78.
79.
Larry A. Weinrauch John A. DElia Matthew R. Weir Suphamai Bunnapradist Peter V. Finn Jiankang Liu Brian Claggett Anthony P. Monaco 《The American journal of medicine》2018,131(2):165-172
Objective
Now that long-term survival after successful renal transplantation is no longer limited by excessive cardiovascular risk, the primary care physician should consider that infection and malignancy are leading noncardiovascular causes of death even in the recipient with diabetes.Methods
We accessed the National Institutes of Health–sponsored Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) study population (4010 renal transplant recipients with elevated homocysteine levels) studied to determine whether folate and B12 supplementation would reduce cardiovascular end points. This trial had a null result. Patients were classified as being nondiabetic or having type 1 or type 2 diabetes.Results
We report an excess (cardiovascular and noncardiovascular) 6-year mortality risk associated with the presence of diabetes mellitus. Two thirds of fatal events in our renal transplant recipients were centrally adjudicated as noncardiovascular. The incidence of noncardiovascular death was 70% higher in the diabetic patient cohort than in the nondiabetic cohort.Conclusions
These results demonstrate that infection (but not malignancy) risks are far higher in diabetic than nondiabetic immunosuppressed individuals (although noncardiovascular death rate in nondiabetic individuals also exceeded cardiovascular deaths) and may play a larger role in the excess mortality populations than previously thought. Given that follow-up in this study was 4 to 10 years after allograft surgery, there was a lesser degree of acute rejection requiring high-dose immunosuppression than in the initial postallograft years. This unique perspective allows transplant recipients to return to primary physicians when taking low doses of immunosuppressive agents and provides focus for follow-up care. 相似文献80.
Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules - a randomised study 总被引:1,自引:0,他引:1
Døssing H Bennedbaek FN Hegedüs L 《European journal of endocrinology / European Federation of Endocrine Societies》2005,152(3):341-345
AIM: To evaluate the efficacy of ultrasound (US)-guided interstitial laser photocoagulation (ILP) on thyroid function, nodule size and patient satisfaction in benign solitary solid cold thyroid nodules by comparing one ILP session with no treatment in a prospective randomised study. MATERIALS AND METHODS: Thirty euthyroid outpatients with a benign solitary solid and a scintigraphically cold thyroid nodule causing local discomfort were assigned to one session of ILP (n = 15) or observation (n = 15) and followed for 6 months. Thyroid nodule volume and total thyroid volume were assessed by US and thyroid function was determined by routine assays before and during follow-up. Pressure and cosmetic complaints before and at 6 months were evaluated on a visual analogue scale. ILP was performed under US guidance and with an output power of 2.5-3.5 W. RESULTS: In the ILP group, the nodule volume decreased from 8.2 ml (6.1; 11.9) (median; quartiles) to 4.8 ml (3.0; 6.6) after 6 months (P = 0.001). The overall median reduction was 44% (37; 52), which correlated with a significant decrease in pressure symptoms as well as cosmetic complaints. In the control group, a non-significant increase in median nodule volume of 7% (0; 34) after 6 months was seen. No major side-effects were seen in the ILP group. There was no correlation between thermal energy deposition and nodule volume reduction. Thyroid function was unaltered throughout. CONCLUSION: US-guided ILP, given as a single treatment, resulted in a satisfactory clinical response in the majority of patients with a benign solitary solid cold thyroid nodule, and may become a clinically relevant alternative to surgery in selected patients. 相似文献